关注
Shengjiang Liu
Shengjiang Liu
CEO&CSO of Avirmax Inc.
在 avirmax.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Inorganic Polyphosphate in Escherichia coli: the Phosphate Regulon and the Stringent Response
NN Rao, S Liu, A Kornberg
Journal of bacteriology 180 (8), 2186-2193, 1998
2781998
Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis.
J Van de Water, A Ansari, T Prindiville, RL Coppel, N Ricalton, BL Kotzin, ...
The Journal of experimental medicine 181 (2), 723-733, 1995
1621995
Binding of the Pyruvate Dehydrogenase Kinase to Recombinant Constructs Containing the Inner Lipoyl Domain of the Dihydrolipoyl Acetyltransferase Component (∗)
S Liu, JC Baker, TE Roche
Journal of Biological Chemistry 270 (2), 793-800, 1995
901995
rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis
W Shen, S Liu, L Ou
Frontiers in immunology 13, 1001263, 2022
802022
Activated function of the pyruvate dehydrogenase phosphatase through Ca2+-facilitated binding to the inner lipoyl domain of the dihydrolipoyl acetyltransferase
G Chen, L Wang, S Liu, C Chuang, TE Roche
Journal of Biological Chemistry 271 (45), 28064-28070, 1996
671996
Development and qualification of a novel virus removal filter for cell culture applications
S Liu, M Carroll, R Iverson, C Valera, J Vennari, K Turco, R Piper, R Kiss, ...
Biotechnology progress 16 (3), 425-434, 2000
502000
Retrospective evaluation of low-pH viral inactivation and viral filtration data from a multiple company collaboration
J Mattila, M Clark, S Liu, J Pieracci, TR Gervais, E Wilson, O Galperina, ...
PDA Journal of Pharmaceutical Science and Technology 70 (3), 293-299, 2016
432016
Detection of minute virus of mice using real time quantitative PCR in assessment of virus clearance during the purification of Mammalian cell substrate derived biotherapeutics
D Zhan, MR Roy, C Valera, J Cardenas, JC Vennari, JW Chen, S Liu
Biologicals 30 (4), 259-270, 2002
432002
Recombinant expression and evaluation of the lipoyl domains of the dihydrolipoyl acetyltransferase component of the human pyruvate dehydrogenase complex
SJ Liu, JC Baker, PC Andrews, TE Roche
Archives of biochemistry and biophysics 316 (2), 926-940, 1995
411995
Reaction mechanism for mammalian pyruvate dehydrogenase using natural lipoyl domain substrates
S Liu, X Gong, X Yan, T Peng, JC Baker, L Li, PM Robben, S Ravindran, ...
Archives of Biochemistry and Biophysics 386 (2), 123-135, 2001
312001
Application of multivirus spike approach for viral clearance evaluation
CR Valera, JW Chen, Y Xu
Biotechnology and bioengineering 84 (6), 714-722, 2003
282003
Systematic comparison of rAAV vectors manufactured using large-scale suspension cultures of Sf9 and HEK293 cells
S Liu, J Li, S Peraramelli, N Luo, A Chen, M Dai, F Liu, Y Yu, RD Leib, Y Li, ...
Molecular Therapy 32 (1), 74-83, 2024
132024
Macular retina-targeting AAV capsid identified through multi-species screening in mice, rabbits, pigs, and monkeys
SS Liu, H Chen, S Peraramelli, N Luo, X Chen, J Li, X Gong, E Santillan, ...
Investigative Ophthalmology & Visual Science 65 (7), 5323-5323, 2024
22024
Proceedings of the 2017 Viral Clearance Symposium, Session 1.2: Upstream Mitigation, Part 2—Virus Barrier Filter and HTST
D Chen, G Bolton
PDA Journal of Pharmaceutical Science and Technology 72 (5), 462-469, 2018
12018
Compositions and methods for transgene expression
S Liu
US Patent App. 18/584,397, 2024
2024
Novel AAV2 capsid expressing Aflibercept shows efficacy and sustainability in rabbit DL-AAA model at picogram level
S Peraramelli, E Santillan, J Li, N Luo, X Chen, K Lin, D Huynh, S Li, L Ou, ...
Investigative Ophthalmology & Visual Science 65 (7), 6163-6163, 2024
2024
Comprehensive comparison of rAAV vectors derived from Sf9 and HEK293 cells for ocular genetherapy
SS Liu
Investigative Ophthalmology & Visual Science 65 (7), 5600-5600, 2024
2024
Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection
S Liu, H Chen, X Chen, N Luo, S Peraramelli, X Gong, MJ Zhang, L Ou
Frontiers in Immunology 15, 1365803, 2024
2024
Compositions and methods for ocular transgene expression
S Liu, H Chen
US Patent App. 18/482,767, 2024
2024
Engineered viral capsids and methods of use
S Liu, H Chen, X Gong
US Patent App. 18/315,312, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20